SFTPC Gene Surfactant Metabolism Dysfunction Type 2 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Respiratory Health
The SFTPC Gene Surfactant Metabolism Dysfunction Type 2 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with severe respiratory conditions in pediatric patients. This specialized genetic test utilizes next-generation sequencing technology to analyze the SFTPC gene, which plays a critical role in surfactant production and lung function maintenance.
What This Test Measures and Detects
This advanced genetic screening specifically targets mutations in the SFTPC (Surfactant Protein C) gene, which encodes a crucial protein component of pulmonary surfactant. The test identifies:
- Point mutations and small insertions/deletions in the SFTPC gene
- Genetic variants associated with surfactant metabolism dysfunction type 2
- Inherited mutations that disrupt normal lung surfactant production
- Genetic markers linked to interstitial lung disease development
- Familial patterns of respiratory disorder inheritance
Who Should Consider This Genetic Test
This specialized genetic analysis is recommended for individuals presenting with:
- Unexplained respiratory distress in infancy or early childhood
- Chronic interstitial lung disease without clear etiology
- Family history of surfactant metabolism disorders
- Persistent respiratory symptoms despite standard treatments
- Suspected genetic basis for respiratory complications
- Children with recurrent pneumonia or breathing difficulties
Clinical Benefits of Genetic Testing
Undergoing the SFTPC gene test provides numerous advantages for patients and healthcare providers:
- Accurate diagnosis of genetic respiratory disorders
- Personalized treatment planning based on genetic findings
- Early intervention opportunities for affected children
- Family genetic counseling and risk assessment
- Improved understanding of disease progression and prognosis
- Guidance for appropriate therapeutic interventions
Understanding Your Test Results
Our comprehensive genetic analysis provides detailed insights into your SFTPC gene status:
- Positive Result: Indicates the presence of SFTPC gene mutations associated with surfactant metabolism dysfunction. This confirms the genetic basis of respiratory symptoms and guides targeted treatment approaches.
- Negative Result: Suggests that SFTPC gene mutations are not detected, helping to rule out this specific genetic cause and directing further diagnostic investigations.
- Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further evaluation and correlation with clinical symptoms.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| SFTPC Gene Surfactant Metabolism Dysfunction Type 2 NGS Genetic DNA Test | $500 USD | $700 USD |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic testing facilities ensures accessibility and convenience for patients nationwide.
Take Control of Your Respiratory Health
Don’t let unexplained respiratory symptoms compromise your quality of life. Our SFTPC Gene Surfactant Metabolism Dysfunction Type 2 NGS Genetic DNA Test provides the clarity needed for accurate diagnosis and effective treatment planning. With advanced NGS technology and expert genetic analysis, we deliver reliable results that can transform patient care.
Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic respiratory health and accessing personalized medical care.
